85-1539-12 Hemopexin, Recombinant Human (HPX, HX, Beta-1B-glycoprotein, FLJ56652, Hemo) 50ug H1865-09A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Hemopexin (HPX) is a 60kD plasma glycoprotein with two four-bladed b-propeller folds. This structural motif has been found in other proteins including collagenases and provides sites for protein-protein interactions (1-3). The liver is the major synthesizing organ. Expression in the central nervous system, in the retina, and in peripheral nerves has also been observed. Hemopexin belongs to the family of the acute-phase proteins whose synthesis is induced after an inflammatory event. Hemopexin participates in maintaining and recycling the iron pool by utilizing its high binding affinity toward heme composed of protoporphyrin IX and iron. It also functions in preventing oxidation caused by heme after hemolysis. Hydrophobic heme molecules can intercalate into lipid membranes and participate in the oxidation of lipid membrane components through the Fenton reaction resulting in lipid peroxidation. Hemopexin undergoes a conformational change upon the binding of heme. The conformational change allows hemopexin to interact with a specific receptor, forming a complex which is then internalized. In the plasma, It is likely that heme binds albumin (35-55 g/L) first because of the higher concentration of albumin in plasma than hemopexin (0.5-1.2 g/L), and is then transferred to hemopexin, which has much higher affinity (Kd ~ 1 pM) toward heme. Heme concentrations in plasma increase after hemolysis, which is associated with several pathological conditions such as reperfusion injury and ischemia.
  • The purified, secreted rhHemopexin has the N-terminal sequence of T24PLPPTSAHG. The 445 amino acid residue rhHemopexin predicts a molecular mass of 50kD and migrates as a 71kD band in SDS-PAGE under reducing conditions.
  • Source: NS0-derived recombinant human Hemopexin with a C-terminal 6X His tag.
  • Activity:Measured by its ability to bind protoporphyrin IX (PPP-IX). See Assay Protocol on the next page for details. Under the described conditions, rhHemopexin binds > 6uM PPP-IX, resulting in 50% decrease in the fluorescence signal of rhHemopexin.
  • Endotoxin: ≤ 1EU/ug of the enzyme as determined by the LAL method.
  • Storage:Samples are stable for up to six months at -20 to -70°C from the date of receipt
  • Upon receiving, the protein can be aliquoted and stored at -20 to -70°C in a manual defrost freezer for three months without a significant loss of activity. Avoid repeated freeze-thaw cycles.

仕様

  • Size:50ug
  • Source Antigen:NS0-derived recombinant human Hemopexin.
  • Grade:Highly Purified
  • Purity:≥ 90%, as determined by SDS-PAGE and visualized by silver stain.
  • Form:Supplied as a liquid in 25mM MES, 0.15M NaCl, pH 6.5.
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1539-12
型番
H1865-09A
入り数
1個
標準価格
298,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:点

お買い物を続ける カートを見る